Blinatumomab Consolidation in Real World
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This will be a multi-center registry for patients with B-ALL. Patient data will be collected both retrospectively and prospectively. The data forms and surveys will be built and managed through REDCap, a secure web application managed by the Clinical \& Translational Science Institute.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Osoby w wieku 18 lat lub starsze.
- •U osób zdiagnozowano ostrą białaczkę limfoblastyczną B-komórkową od 1 grudnia 2022 roku.
- •Nie otrzymali leku blinatumomab w ramach badania klinicznego.
- •Wyrażają zgodę na udział w badaniu (lub dane osób zmarłych).
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- July 31, 2026
- Sex
- No restrictions
Locations (3)
Mayo Clinic Cancer Center
Jacksonville, United States
University of Pennsylvania
Philadelphia, United States
Medical College of Wisconsin
Milwaukee, United States
Trial contact
Arielle Baim
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 8/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.